[Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D010636:Phenols / Q000627:therapeutic use
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001593:Benzyl Compounds; D006834:Hydrazines; D010636:Phenols; D007980:Levodopa; D001545:Benserazide; D002230:Carbidopa
Les inhibiteurs de la décarboxylase associés à la L Dopa dans le traitement de la maladie de Parkinson